ORASURE TECHNOLOGIES, INC Accounts Payable
ORASURE TECHNOLOGIES, INC (OSUR) had Accounts Payable of $8.40 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $8.40M.
- 2026-03-31: Accounts Payable, Current $10.63M.
- 2025-12-31: Accounts Payable, Current $6.52M.
- 2025-09-30: Accounts Payable, Current $6.36M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.40M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $10.63M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $6.52M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $6.36M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $6.38M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $7.82M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $8.17M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $9.58M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $9.09M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $12.68M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $13.15M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $14.97M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $17.75M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $27.40M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $38.02M 10-K · filed 2024-03-11 | $39.35M 10-K · filed 2023-03-03 |
| 2022-09-30 | $40.37M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $36.23M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $27.06M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $28.02M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $23.78M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $22.12M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $20.73M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $17.41M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $14.38M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $9.06M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $6.88M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $9.57M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $9.78M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $10.96M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $10.64M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.60M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $8.06M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.66M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $9.62M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $10.23M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $9.62M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.62M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $7.29M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.63M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $4.42M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $3.96M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $5.29M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $5.09M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $6.96M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.73M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $5.04M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $7.15M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $4.51M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $4.65M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $4.11M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.83M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $3.86M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $3.38M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $5.62M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $3.38M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $5.13M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $4.30M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $3.53M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $4.14M 10-K · filed 2013-03-13 | $4.14M 10-K · filed 2012-03-14 |
| 2011-09-30 | $3.48M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $3.72M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $2.90M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |